-
January 28, 2013
Pfizer (PFE) is slated to report its second quarter 2012 earnings on July 31, 2012 before the opening bell. The ...
-
January 24, 2013
Amgen (AMGN) reported fourth quarter 2012 earnings of $1.39 per share, 4 cents below the Zacks Consensus Estimate. ...
-
January 23, 2013
Pfizer Inc. (PFE) recently received a positive opinion from the European Medicines Agency's (EMA) Committee for ...
-
January 23, 2013
Pfizer filed further details about its tentative spin-off of Zoetis, its animal health business.
-
January 22, 2013
The US Patent and Trademark Office (USPTO) recently extended the patent covering Spectrum Pharmaceuticals' (SPPI) ...
-
January 22, 2013
Sanofi (SNY) recently announced that its epinephrine injection, Allerject, is available in Canada for the emergency ...
-
January 21, 2013
Bristol-Myers Squibb Company (BMY) is scheduled to release its fourth-quarter 2012 results before the opening bell ...
-
January 17, 2013
AstraZeneca (AZN) recently announced that the company has created seven positions in the senior executive team. At ...
-
January 17, 2013
Pfizer Inc. (PFE) recently announced that it has launched its attention deficit hyperactivity disorder (ADHD) ...
-
January 17, 2013
Forest Labs' miss doesn't seem like a thesis-changing event.
-
January 14, 2013
As per recent data published in The Lancet, Novartis' (NVS) cancer drug, Afinitor (everolimus), helped reduce the ...
-
January 14, 2013
ArQule Inc. (ARQL) and partner Daiichi Sankyo recently announced disappointing phase II results on oncology ...
-
January 11, 2013
Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust ...
-
January 09, 2013
Onyx Pharmaceuticals, Inc. (ONXX) recently provided an update on its performance in 2012 and its plans for 2013. ...
-
January 08, 2013
Repligen Corporation (RGEN) recently joined forces with Pfizer, Inc. (PFE) for the advancement of its spinal ...
-
January 08, 2013
Biogen Idec (BIIB) recently submitted a Biologics License Application (BLA) seeking US Food and Drug Administration ...
-
January 02, 2013
Mylan Inc.(MYL) recently announced that it has launched its generic version of Pfizer's (PFE) Dilantin Chewable ...
-
January 02, 2013
Mallinckrodt, the Pharmaceuticals business of Covidien plc (COV), has won the U.S. Food and Drug Administration ...
-
December 31, 2012
Specialty pharmaceutical company, Emergent BioSolutions (EBS), recently signed a license agreement to gain an ...
-
December 31, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner Pfizer Inc. (PFE) received some encouraging news when the ...
